Posts by Helene Kuhn
Sepset’s Sepsis Signature
BioCentury Senior Writer Michael Leviten discusses gene expression tests that could speed up diagnosis of sepsis.
Read MoreAppointments and advancements – Fayyaz Memon
Immunexpress continues executive team expansion with addition of Fayyaz Memon as VP of Regulatory Affairs & Quality.
Read MoreAppointments and advancements – Rolland Carlson, Tanja Dowe, Katleen Verleysen
Immunexpress strengthens Board of Directors with key appointments.
Read MoreProduct Briefs – SeptiCyte LAB
Immunexpress, Inc. published in the American Journal of Respiratory and Clinical Care Medicine the design and results of clinical trials validating SeptiCyte™ LAB in the discrimination of sepsis from non-infectious systemic inflammatory response syndrome (SIRS) in the Intensive Care Unit (ICU) of hospitals.
Read MoreValidation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU
Miller et al., American Journal of Respiratory and Critical Care Medicine | SeptiCyte LAB appears to be a promising diagnostic tool to complement physician assessment of infection likelihood in critically ill adult patients with systemic inflammation.
Read MoreBiocartis Partnership May Enable Immunexpress to Move Sepsis Test to Point of Care
Biocartis Group NV (‘Biocartis’), an innovative molecular diagnostics company and Immunexpress have entered into a partnership agreement aimed at the development and commercialization of Immunexpress’ SeptiCypte™ test for use on Biocartis’ sample-to-result Idylla™ platform.
Read MoreBrief-Biocartis & Immunexpress Partnership For A Sepsis Host Immune Response Test
Immunexpress and Biocartis enter an agreement to develop and commercialize SeptiCyte™ technology for use on sample-to-result Idylla™ platform.
Read MoreBiocartis, Immunexpress Partner to Develop Sepsis Test
Biocartis and Immunexpress partner to develop a fully automated sepsis test, allowing for fast near-patient testing, resulting in potentially life-saving clinical information.
Read MoreBiocartis, Immunexpress Partner to Develop Sepsis Test
Biocartis & Immunexpress sign partnership for a sepsis host immune response test on the Idylla™ platform.
Read MoreDifferentiating sepsis and systemic inflammatory response syndrome using biomarkers
An interview with Dr. Richard Brandon, Chief Scientific Officer, Immunexpress, conducted by April Cashin-Garbutt, MA (Cantab).
Read More